UnitedHealth Group is a top dividend growth stock with strong financials and potential for 20%+ returns by 2026. Read more ...

Analyst Erin Wright of Morgan Stanley maintained a Buy rating on UnitedHealth (UNH – Research Report), retaining the price target of ...

UnitedHealth Group will host its annual Investor Conference for analysts and institutional investors in New York City on Wednesday, December 4, 2024, beginning at 8:00 a.m. EST.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.23% of ...

Mairs & Power Growth Fund highlighted stocks like UnitedHealth Group Incorporated (NYSE:UNH) in the third quarter 2024 investor letter. UnitedHealth Group Incorporated (NYSE:UNH) is a diversified ...

UnitedHealthcare overcomes challenges for long-term success, targets 13-16% earnings growth, presents buying opportunity with $700 price target by 2025.

Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2024 investor letter ...

This is part 5 of Health Care's Colossus, a series about how UnitedHealth Group wields its unrivaled physician empire to boost its profits and expand its influence. UnitedHealth Group is paying ...

UnitedHealth Group (UNH) closed at $606.79 in the latest trading session, marking a +0.16% move from the prior day. This change lagged the S&P 500's 0.57% gain on the day. On the other hand, the Dow ...

Mairs & Power, an investment advisor, released the “Mairs & Power Growth Fund” third quarter 2024 investor letter. A copy of ...